Drug: Bevacizumab Injury: Hyponatraemia Quarter: 2016Q3
Total Records: 29 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 89228356 | Bevacizumab | Hyponatraemia | ROCHE | 0.00 | 0 | 20160914 | US | |
| 94583572 | Bevacizumab | Hyponatraemia | ROCHE | 66.00 YR | F | 54 KG | 20160929 | US |
| 97780392 | Bevacizumab | Hyponatraemia | ROCHE | 62.00 YR | F | 65 KG | 20160929 | US |
| 104009286 | Bevacizumab | Hyponatraemia | ROCHE | 0.00 | 0 | 20160916 | DE | |
| 107434093 | Bevacizumab | Hyponatraemia | ROCHE | 39.00 YR | M | 102 KG | 20160905 | US |
| 114578486 | Bevacizumab | Hyponatraemia | ROCHE | 78.49 YR | M | 74 KG | 20160726 | US |
| 125281901 | BEVACIZUMAB | Hyponatraemia | JANSSEN | 0.00 | 0 | 20160705 | US | |
| 125404372 | Bevacizumab | Hyponatraemia | ROCHE | 66.00 YR | M | 55 KG | 20160808 | US |
| 125483631 | BEVACIZUMAB | Hyponatraemia | MERCK | 0.00 | 0 | 20160712 | US | |
| 126017902 | Bevacizumab | Hyponatraemia | ROCHE | 53.00 YR | M | 0 | 20160804 | JP |
| 126155961 | BEVACIZUMAB | Hyponatraemia | BRISTOL MYERS SQUIBB | 51.00 YR | M | 0 | 20160802 | US |
| 126883782 | Bevacizumab | Hyponatraemia | ROCHE | 0.00 | 0 | 20160828 | CN | |
| 127138881 | Bevacizumab | Hyponatraemia | ROCHE | 51.00 YR | M | 70 KG | 20160905 | US |
| 127154622 | Bevacizumab | Hyponatraemia | ROCHE | 0.00 | 0 | 20160907 | US | |
| 127174031 | BEVACIZUMAB | Hyponatraemia | JANSSEN | 0.00 | F | 0 | 20160906 | US |
| 127335871 | Bevacizumab | Hyponatraemia | ROCHE | 0.00 | F | 0 | 20160912 | US |
| 127362261 | Bevacizumab | Hyponatraemia | ROCHE | 77.00 YR | M | 73 KG | 20160913 | US |
| 127412081 | Bevacizumab | Hyponatraemia | ROCHE | 47.00 YR | M | 114 KG | 20160914 | US |
| 127413061 | Bevacizumab | Hyponatraemia | ROCHE | 56.00 YR | F | 48 KG | 20160914 | US |
| 127414771 | Bevacizumab | Hyponatraemia | ROCHE | 59.00 YR | F | 108 KG | 20160914 | US |
Total Records: 29 Number of Pages: 2